According to two sequencing studies on 227 cases of ESCC, NRF2, KEAP1, and CUL3 mutation took place in 5.28%, 2.8%, and 0.9% cases, respectively (Figure 2A). This evidence concerns the gene KEAP1 and esophageal squamous cell carcinoma.